Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE ® + One Infusion of Sipuleucel-T

Conditions: Metastatic Castration-Resistant Prostate Cancer (mCRPC) Interventions: Drug: Sipuleucel-T Injection Sponsors: Dendreon Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials